| Literature DB >> 22553261 |
Joanna H Zurawska1, Rachel Jen1, Stephen Lam2, Harvey O Coxson3, Jonathon Leipsic4, Don D Sin5.
Abstract
Lung cancer is the leading cause of cancer-related mortality in the United States and around the world. There are > 90 million current and ex-smokers in the United States who are at increased risk of lung cancer. The published data from the National Lung Screening Trial (NLST) suggest that yearly screening with low-dose thoracic CT scan in heavy smokers can reduce lung cancer mortality by 20% and all-cause mortality by 7%. However, to implement this program nationwide using the NLST inclusion and exclusion criteria would be extremely expensive, with CT scan costs alone > $2 billion per annum. In this article, we offer a possible low-cost strategy to risk-stratify smokers on the basis of spirometry measurements and emphysema scoring by radiologists on CT scans.Entities:
Mesh:
Year: 2012 PMID: 22553261 PMCID: PMC3415147 DOI: 10.1378/chest.11-1863
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410